Only for sale to professional users such as doctors, pharmacists, alternative practitioners and other medically trained personnel.
Rapid antigen detection test for SARS-CoV-2 antigen in human nasal or nasopharynx secretions
According to CDC’s guidance, COVID-19 antigen test has the best sensitivity from day 1 to day 5 after the onset of symptoms. Antigen levels in specimens collected beyond 5–7 days of the onset of
symptoms may drop below the limit of detection of the test.
PreventID® SARS-CoV-2-Antigen detects Nucleocapsid Protein (N-Protein) Antigen, the major structural protein that binds to the SARS-CoV-2 RNA genome. It doesn’t detect SARSCoV-2 surface protein („Spike“). N-Protein is much more stable than the Spike Protein. Therefore, any mutation in Spike protein of genetic SARS-CoV-2, such as Brazil Variant P.1, Delta Variant B.1.617.2 and Omicron Variant (B.1.1.529) can be detected by PreventID® SARS-CoV-2-Antigen, as mutations have no interference with the sensitivity.